Arizona Tribune - Boulevard

NYSE - LSE

SCS	0.12%	16.14	$
RBGPF	0.12%	82.5	$
CMSC	-0.04%	23.75	$
CMSD	0.12%	24.08	$
NGG	-0.78%	84.61	$
GSK	1.66%	52.47	$
RIO	1.61%	92.52	$
BCE	-0.12%	25.83	$
BTI	0.51%	60.99	$
BP	-0.48%	37.7	$
RELX	-0.76%	35.53	$
RYCEF	1.65%	16.95	$
AZN	0.7%	188.41	$
BCC	1.15%	81.75	$
JRI	0.53%	13.15	$
VOD	1.74%	14.91	$

Featured

US judge to hear request for 'immediate takedown' of Epstein files

A US federal judge said he would hear a request to block access to investigative files linked to sex offender Jeffrey Epstein on Wednesday, after lawyers flagged unredacted names of victims.

Malaysian court acquits French man on drug charges

A French national facing a possible death sentence in Malaysia on eight drug-related charges was acquitted Tuesday, freeing him after nearly two and a half years in detention.

Last news

Newsmax to Report Third Quarter 2025 Financial Results

BOCA RATON, FL / ACCESS Newswire / October 28, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced that the Company will report financial results for the third quarter ended September 30, 2025 on Thursday, November 13, 2025, after the U.S. stock market closes.

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Momentum has a way of separating the contenders from the crowd. Sunshine Biopharma (NASDAQ:SBFM) is quickly establishing which side of that line it's on. After scoring another major regulatory win, that position certainly isn't one of many in the crowd. On Tuesday, the company announced that it had secured Health Canada authorization to commercialize domperidone through its Nora Pharma subsidiary, a milestone that not only expands its commercial reach but also validates its growing track record of revenue-generating execution.

Who is Javad Sajan?

Javad Sajan is the best plastic surgeon in Seattle.

Vanderbilt Report NextTrip CEO Interview: NextTrip Builds What Traditional Travel Companies Couldn't

BRISTOL, TN / ACCESS Newswire / October 28, 2025 / Most online travel agencies can't prove their advertising works.

Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA

Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage.

Medical Care Technologies Inc. (OTC PINK:MDCE) Nears Completion of AI-Powered App Targeting the $4.5 Billion Global Nutrition & Recipe Market

MESA, ARIZONA / ACCESS Newswire / October 28, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has entered its final development phase. The app uses image recognition to create recipes and also analyzes nutrition data directly from food photos. MDCE plans to deploy the app in 175 countries and in over 30 languages.

Dolphin (NASDAQ:DLPN) Named One of Crain's Best Places to Work in NYC 2025

NEW YORK, NY / ACCESS Newswire / October 28, 2025 / Dolphin (NASDAQ:DLPN) is proud to announce it has been recognized by Crain's New York Business as one of the Best Places to Work in New York City for 2025. The annual ranking honors companies that go above and beyond in creating workplaces defined by collegiality, collaboration, and care. Employers are evaluated on leadership, culture, professional development, benefits, and employee satisfaction.

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

DENVER, CO / ACCESS Newswire / October 28, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that the method of use patent (U.S. Patent No. 7,538,116) for EXXUATM (gepirone) extended-release tablets ("EXXUA") has been extended through September 2, 2030 under 35 U.S.C. 156. The patent extension further expands upon the new chemical entity ("NCE") exclusivity period granted by the United States Food and Drug Administration ("FDA"). Gepirone is an NCE, and EXXUA is the first-in-class selective serotonin 5HT1a receptor agonist approved by the FDA for the treatment of major depressive disorder ("MDD") in adults.

The NITE FLAG XL Launches October 28, 2025 - The Flag of the 21st Century

THE FUTURE OF FLAGS IS NOW- THE NITE FLAG COMPANY"Always Waves. Never Sags. Lights Up the Night."

Modular Medical Announces Ongoing Progress to Obtain CE Mark

Key Highlights:Pivot continues to progress toward CE Mark certification in 2026Stage 1 ISO Audit completed with Stage 2 planned for 1H2026

VSee Awarded US Department of Health & Human Services FedRAMP High ATO

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 28, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), announced it has received its Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services (HHS). The authorization also allows other federal agencies to use VSee where FedRAMP High is required.

Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud

ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace.

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

FORT LAUDERDALE, FL / ACCESS Newswire / October 28, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company focused on innovative and affordable healthcare solutions, today announced that its wholly owned subsidiary, Nora Pharma Inc., has received approval from Health Canada, the Canadian equivalent to the FDA, for the commercialization of Domperidone, a prescription medication used to relieve nausea and vomiting and to enhance gastrointestinal motility.

Date Change for Bike MS: Historic New Bern Ride 2026!

Cycling for a Cure to End Multiple Sclerosis

CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies

Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition.

Venezuela claims CIA 'false flag' attack foiled, as US deploys bombers

Venezuela claimed Monday to have dismantled a CIA-financed cell plotting a false-flag attack on a US warship deployed to the southern Caribbean, as Washington stepped up pressure on Caracas by flying bombers nearby.

Brazil ex-leader Bolsonaro appeals 27-year prison sentence

Former Brazilian president Jair Bolsonaro's lawyers on Monday filed an appeal against his 27-year prison sentence for a botched coup bid after his 2022 election loss.

'Not our first hurricane': Jamaicans prepare to ride out deadly Melissa

Melissa could be the worst hurricane Jamaica has experienced since recordkeeping began -- but some residents on the Caribbean island say they will believe it when they see it.

AI-generated fakes proliferate as Hurricane Melissa nears Jamaica

AI-generated videos were clogging social media feeds Monday as Hurricane Melissa surged toward Jamaica, diverting attention from critical safety information about the massive Category 5 storm.

NBA reviewing policies to fight 'dire risks' of gambling: report

The NBA is reviewing league policies to ensure players know gambling's "dire risks" according to a league memo reportedly sent to teams Monday in the wake of a betting scandal.

American jazz drummer Jack DeJohnette dies

US jazz drummer Jack DeJohnette, a major figure in modern jazz who collaborated with Miles Davis and Keith Jarrett, has died at 83, his management said on Monday.

'A kind of freedom': Amsterdam celebrates 750 years

World-famous city of canals, bikes and tolerance, Amsterdam celebrated 750 years since its founding Monday, but the Dutch capital is now grappling with the very modern problems of overtourism and a housing shortage.

UK activists who tried to paint Taylor Swift jet spared jail

Two climate activists were Monday spared jail by a UK court after they sprayed two planes with orange paint to protest US pop star Taylor Swift's use of private jets.

Category 5 Hurricane Melissa strengthens as it heads for Jamaica

Hurricane Melissa strengthened Monday as it took aim at Jamaica and other parts of the Caribbean as a top-level Category 5 storm, with forecasters predicting catastrophic flooding and urging residents to seek shelter immediately.

Australian Murray cod wallops swim record

An Australian freshwater Murray cod has surprised scientists by swimming a marathon 860 kilometres (530 miles) along a major river system -- believed to be a record for the species.

Murder, kidnap, censorship: the 'new normal' of Tanzania politics

A priest attacked after a meeting about democracy with faith leaders, an opposition official's corpse found doused in acid, an ex-ambassador missing from his blood-stained home -- this is the "new normal" in Tanzania, say critics.

Venezuela says US military exercises on nearby island a 'provocation'

Venezuela on Sunday blasted the arrival in nearby Trinidad and Tobago of a US warship as a dangerous "provocation," amid mounting fears of potential attacks against the Venezuelan mainland.

Menhaden Fisheries Coalition Refutes False Claims by Chesapeake Bay Foundation's Chris Moore

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / At a Chesapeake Bay Foundation (CBF) event titled "The Impacts of Climate on Fisheries," held on September 24, 2025, at the Virginia Aquarium & Marine Science Center in Virginia Beach, Chris Moore, CBF's Senior Regional Ecosystem Scientist, made several inaccurate statements about the Atlantic menhaden fishery and its management.

Forte Group Announces Amended Terms to Previously Announced Warrant Amendment

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / October 27, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z) ("Forte Group" or the "Company"), a next-generation beverage and nutraceutical company focused on longevity and human performance, announces that further to its news release dated October 10, 2025 (the "Initial Disclosure"), which outlined its intention to amend the price and term of an aggregate of 1,152,937 common share purchase warrants (the "Repriced Warrants") aimed at strengthening its financial position, the Company advises that it will amend the exercise price of the Repriced Warrants to $0.30 per share, effective October 24, 2025, in accordance with Policy 6.7(6)(b) of the Canadian Securities Exchange ("CSE").

Statement of the Menhaden Fisheries Coalition on the Upcoming Atlantic Menhaden Management Board Meeting

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / Tomorrow, the Atlantic States Marine Fisheries Commission's Menhaden Board is slated to take up several issues which have the potential to gravely impact this historic fishery. First, it will consider the results of the menhaden and ecological reference points ("ERP") stock assessment. Despite a lower estimate of menhaden fecundity, the stock status remains not overfished and overfishing is not occurring. The assessment team attributed this to the fact that menhaden "management has consistently been more conservative than single-species reference points would have historically prescribed."

Newsmax Signs Deal to Make Channel Available in 900+ Hotels, 300,000 Rooms Nationwide

BOCA RATON, FL / ACCESS Newswire / October 27, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced a new agreement with the leading provider of in-room entertainment for the hospitality industry that delivers the Newsmax channel to more than 900 hotels and 300,0000 hotel rooms across the U.S.

Menhaden Misinformation: Four Organizations Push Drastic Cuts that Contradict the Assessment Record and Ecosystem-Based Management

WASHINGTON, DC / ACCESS Newswire / October 27, 2025 / The Chesapeake Bay Foundation (CBF), American Sportfishing Association (ASA), Theodore Roosevelt Conservation Partnership (TRCP), and the American Saltwater Guides Association (ASGA) are circulating claims about Atlantic menhaden that don't match the assessment record or how this fishery is managed.

Arizona Tribune - Boulevard (English)